Metraipolis › archive › dc_4e27cf1d3ae7

Cancer-associated fibroblasts at the crossroads of tumor progression and therapy resistance: from heterogeneity to precision reprogramming — Europe PMC PMID:41423542

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41423542
DOI
10.1186/s43046-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-07T11:37:01.512Z
SHA-256 of the archived text
210a2699b091e934a2a68f018f13f88df3154a85caa6f6a0817a6632d6ad4cf4
Stable URL of this page
https://metraipolis.com/documento/dc_4e27cf1d3ae7

How to cite

Cancer-associated fibroblasts at the crossroads of tumor progression and therapy resistance: from heterogeneity to precision reprogramming — Europe PMC PMID:41423542 — Europe PMC (en), https://europepmc.org/article/MED/41423542 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e27cf1d3ae7 (Metraipolis archive dc_4e27cf1d3ae7, sha256 210a2699b091e934a2a68f018f13f88df3154a85caa6f6a0817a6632d6ad4cf4)
BibTeX
@misc{dc4e27cf1d3ae7,
  title = {Cancer-associated fibroblasts at the crossroads of tumor progression and therapy resistance: from heterogeneity to precision reprogramming — Europe PMC PMID:41423542},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41423542},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e27cf1d3ae7; sha256 210a2699b091e934a2a68f018f13f88df3154a85caa6f6a0817a6632d6ad4cf4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41423542. Agents can read the archived copy with the MCP tool read_document.